Skip to main content
Journal cover image

Transplantation Outcomes for Children with Severe Combined Immune Deficiency (SCID) Have Improved over Time: A 36-Year Summary Report By the Primary Immune Deficiency Treatment Consortium (PIDTC)

Publication ,  Conference
Thakar, MS; Logan, B; Buckley, RH; Haddad, E; Dvorak, CC; O'Reilly, RJ; Kapoor, N; Satter, LF; Martinez, C; Pai, S-Y; Heimall, J; Jyonouchi, S ...
Published in: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
March 1, 2020

Duke Scholars

Published In

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

EISSN

1523-6536

ISSN

1083-8791

Publication Date

March 1, 2020

Volume

26

Issue

3

Start / End Page

S18 / S19

Location

Orlando, FL

Publisher

ELSEVIER SCIENCE INC

Conference Name

Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Thakar, M. S., Logan, B., Buckley, R. H., Haddad, E., Dvorak, C. C., O’Reilly, R. J., … Notarangelo, L. D. (2020). Transplantation Outcomes for Children with Severe Combined Immune Deficiency (SCID) Have Improved over Time: A 36-Year Summary Report By the Primary Immune Deficiency Treatment Consortium (PIDTC). In BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (Vol. 26, pp. S18–S19). Orlando, FL: ELSEVIER SCIENCE INC.
Thakar, Monica S., Brent Logan, Rebecca H. Buckley, Elie Haddad, Christopher C. Dvorak, Richard J. O’Reilly, Neena Kapoor, et al. “Transplantation Outcomes for Children with Severe Combined Immune Deficiency (SCID) Have Improved over Time: A 36-Year Summary Report By the Primary Immune Deficiency Treatment Consortium (PIDTC).” In BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26:S18–19. ELSEVIER SCIENCE INC, 2020.
Thakar MS, Logan B, Buckley RH, Haddad E, Dvorak CC, O’Reilly RJ, et al. Transplantation Outcomes for Children with Severe Combined Immune Deficiency (SCID) Have Improved over Time: A 36-Year Summary Report By the Primary Immune Deficiency Treatment Consortium (PIDTC). In: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. ELSEVIER SCIENCE INC; 2020. p. S18–9.
Thakar, Monica S., et al. “Transplantation Outcomes for Children with Severe Combined Immune Deficiency (SCID) Have Improved over Time: A 36-Year Summary Report By the Primary Immune Deficiency Treatment Consortium (PIDTC).” BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, vol. 26, no. 3, ELSEVIER SCIENCE INC, 2020, pp. S18–19.
Thakar MS, Logan B, Buckley RH, Haddad E, Dvorak CC, O’Reilly RJ, Kapoor N, Satter LF, Martinez C, Pai S-Y, Heimall J, Jyonouchi S, Sullivan KE, Chandra S, Smith AR, Chaudhury S, Saldana BD, Sunkersett G, Shyr DC, Burroughs LM, Petrovic A, Quigg TC, Shenoy S, Bednarski JJ, DeSantes K, Cuvelier GDE, Chandrakasan S, Gillio AP, Knutsen AP, Eissa H, Goldman F, Moore TB, Aquino V, Shereck E, Lugt MV, Caywood EH, Yu LC, Rozmus J, Talano J-AM, Malech HL, Shah AJ, Abu-Arja R, Miller HK, Bani-Hashemi T, Chang CK, Dunn E, Torgerson T, Pulsipher MA, Griffith LM, Cowan MJ, Kohn DB, Puck J, Notarangelo LD. Transplantation Outcomes for Children with Severe Combined Immune Deficiency (SCID) Have Improved over Time: A 36-Year Summary Report By the Primary Immune Deficiency Treatment Consortium (PIDTC). BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. ELSEVIER SCIENCE INC; 2020. p. S18–S19.
Journal cover image

Published In

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

EISSN

1523-6536

ISSN

1083-8791

Publication Date

March 1, 2020

Volume

26

Issue

3

Start / End Page

S18 / S19

Location

Orlando, FL

Publisher

ELSEVIER SCIENCE INC

Conference Name

Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences